Gannong Chen

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Journal: Experimental and therapeutic medicine

Published: September 10, 2021

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data.

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 05, 2021

Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.

Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.

Journal: Frontiers in oncology

Published: January 30, 2021

miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway.

miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway.

Journal: Cellular signalling

Published: June 14, 2020

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.

Journal: Frontiers in oncology

Published: January 23, 2020

TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.

TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.

Journal: Journal of cellular biochemistry

Published: March 27, 2017

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Journal: Experimental and therapeutic medicine

Published: August 04, 2015

Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy.

Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy.

Journal: Clinical therapeutics

Published: June 25, 2015

Benefit finding predicts depressive and anxious symptoms in women with breast cancer.

Benefit finding predicts depressive and anxious symptoms in women with breast cancer.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: April 22, 2015

Psychometric features of the body image after breast cancer questionnaire-Chinese version in women with breast cancer

Psychometric features of the body image after breast cancer questionnaire-Chinese version in women with breast cancer

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: January 30, 2014

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.

Journal: PloS one

Published: November 09, 2013

What factors are predictive of benefit finding in women treated for non-metastatic breast cancer? A prospective study.

What factors are predictive of benefit finding in women treated for non-metastatic breast cancer? A prospective study.

Journal: Psycho-oncology

Published: October 08, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026